Business
Why the Immutep (ASX:IMM) share price jumped 9% higher today
In morning trade the Immutep Ltd (ASX: IMM) share price is storming higher following the release of an announcement.
At the time of writing, the biotechnology company’s shares are up 9% to 42.5 cents.
What did Immutep announce?
This morning the developer of novel immunotherapy treatments for cancer and autoimmune disease announced that it has received a patent entitled “Combined Preparations for the Treatment of Cancer or Infection” by the United States Patent & Trade Mark Office.
According to the release, this US patent follows the grant of the corresponding European patent announced in November 2018.
The claims of the patent protect Immutep’s intellectual property relating to combined preparations comprising its lead…
-
Business16 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business19 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
General16 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips
-
Business15 hours agoHere’s what analysts expect for the BHP share price in the coming year